Background
swapnil hiremath
The KDIGO CKD 2024 Guidelines Part 1: ...

This week, we will discuss the 2024 KDIGO Guidelines on CKD, part 1. In this section we will discuss the first two chapters on CKD evaluation and risk stratification. Let’s dive in!

The KDIGO CKD 2024 Guidelines Part 1: Evaluation and Risk Stratification
Background
Jade Teakell
Shedding Light on the Dense Matter of C3 ...

This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.

Shedding Light on the Dense Matter of C3 Glomerulopathy
Background
swapnil hiremath
Healing, Hype, or Harm: The NefIgArd trial

This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?

Healing, Hype, or Harm: The NefIgArd trial
Background
Cristina Adriana Popa
PRAECISely Predicting Preeclampsia

This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.

PRAECISely Predicting Preeclampsia
Background
swapnil hiremath
The Worldwide Shadow of Kidney Disease

This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.

The Worldwide Shadow of Kidney Disease

#NephJC on the facebook app: wrap up

We had a few hiccups for this chat: the authors, Komal Kumar, Betsy King did join us for the first chat - and so did some other staff from Hopkins ERGOT workgroup, but twitter gave a lot of troubles the next day. Tweets were not showing up - so we called it a day, and rescheduled the chat to Sep 28. Things did work out this time!

Does Regional Anesthesia Improve Fistula failure rates? The #NephJC wrapup

Fistula Failure: Can Anesthesia Solve our Vexing Vascular Access Problems?

Fistula Failure: Can Anesthesia Solve our Vexing Vascular Access Problems?

Historically nephrology is a specialty that has been criticized for it’s inability to produce high quality randomized controlled clinical trials designed to answer a specific question. So, when the Lancet publishes the results of a clinical trial in the field it is worth taking note.